Avelios Medical is a technology company.
Avelios Medical has raised $31.0M across 1 funding round.
Avelios Medical has raised $31.0M in total across 1 funding round.
Avelios Medical has raised $31.0M in total across 1 funding round.
Avelios Medical's investors include Sequoia Capital.
Avelios Medical is a Munich-based healthcare technology company developing a modern hospital information system (HIS) that digitizes and optimizes hospital workflows using a modular microservices platform and fully structured data.[1][2][3] The platform serves hospitals and healthcare providers by addressing inefficiencies in legacy systems, enabling data-driven patient care, AI integration, automated documentation, billing, and patient portals to treat more patients more effectively.[1][3][5] With strong growth momentum, including a €2 million seed round in 2021 led by Revent and High-Tech Gründerfonds, followed by a €30 million ($31.1 million) Series A in February 2025 led by Sequoia Capital, Avelios has gained adoption by major players like Sana (Germany's largest private hospital chain with 56 facilities), Ludwig-Maximilians-University Munich, and Hannover Medical School.[2][3][5]
Founded in 2020 by Christian Albrecht (CEO), Nicolas Jakob (CTO), and Dr. Sebastian Krammer (Chief Medical Officer), Avelios emerged from the founders' recognition of systemic flaws in outdated hospital IT systems, exacerbated by COVID-19 inefficiencies in Germany.[3][5] Albrecht, Jakob, and Krammer—leveraging expertise in engineering, technology, and medicine—built an advanced HIS to empower clinicians rather than burden them with administrative tasks.[3][5] Early traction came quickly: a €2 million seed funding round in November 2021 from Revent, High-Tech Gründerfonds, and business angels enabled initial deployments, setting the stage for rapid scaling and the landmark Series A.[2]
Avelios rides the wave of digital health transformation, replacing decades-old legacy hospital IT with AI-powered, cloud-native systems amid post-COVID funding boosts and regulatory pushes for modernization in Europe.[5] Timing is ideal: Europe's healthcare digitization lags but faces mounting pressures from staffing shortages, rising costs, and AI advancements, favoring modular solutions over rigid incumbents.[3][5] Market forces like government incentives in Germany and demand from leading hospitals amplify its momentum, while adoption by chains like Sana influences ecosystem-wide shifts toward interoperable, data-driven care.[3] By enabling AI use cases, Avelios accelerates broader trends in precision medicine and workflow automation.
Avelios is poised for aggressive expansion, using its Series A to enhance the platform, enter markets like Spain, France, and the U.K., and deepen AI capabilities with its 11-doctor team and efficient engineering.[5] Trends like AI proliferation in healthcare and modular SaaS adoption will propel it, potentially disrupting entrenched players as hospitals prioritize scalable upgrades. Its influence may evolve from German pioneer to pan-European leader, redefining HIS as an enabler of superior patient care—delivering on its promise to treat more patients better.[1][3]
Avelios Medical has raised $31.0M across 1 funding round. Most recently, it raised $31.0M Series A in February 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2025 | $31.0M Series A | Sequoia Capital |